Sealing the source
Emergency preparedness staff and scientists at the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) were formally recognised for their work locating a lost radioactive source in Western Australia’s Pilbara region.
SyMo
ANSTO is in the process of constructing the SyMo facility which is intended to utilise SYNROC technology to immobilise waste from ANSTO’s Mo-99 production processes.
Progress on actions from ANSTO safety review
On 29 June 2018, the ARPANSA CEO issued a Direction to ANSTO to initiate an independent safety review following a series of events with safety implications at the ANSTO Health (now Health Products) facility. ARPANSA has been monitoring progress against the implementation plan and is generally satisfied with the actions taken to date.
ARPANSA authorises ANSTO Nuclear Medicine facility to return to routine operation
On 27 March 2020, the CEO of ARPANSA, Dr Carl-Magnus Larsson, removed a licence condition from the ANSTO Nuclear Medicine (ANM) facility, allowing it to return to routine operation.
ARPANSA approves ANSTO implementation plan following safety review
In June 2018, ARPANSA issued a direction to its licence holder, the Australian Nuclear Science and Technology Organisation (ANSTO), to initiate an independent review of its approach to occupational radiation safety at its nuclear medicine facility operated by ANSTO Health, now known as Health Products.
Contamination event at ANSTO Nuclear Medicine facility
On Friday 21 June 2019, ARPANSA was notified of a radiation contamination event at the Australian Nuclear Science and Technology Organisation (ANSTO) Nuclear Medicine (ANM) production facility in Lucas Heights, New South Wales.
ARPANSA authorises ANSTO to commence routine production of molybdenum-99 in the ANM facility
ARPANSA’s CEO, Dr Carl-Magnus Larsson has amended a licence issued to the Australian Nuclear Science and Technology Organisation (ANSTO) to operate the ANSTO Nuclear Medicine (ANM) facility.
ARPANSA authorises limited production of molybdenum-99 in the ANM facility
ARPANSA has granted the Australian Nuclear Science and Technology Organisation (ANSTO) an amended license to allow for the limited production of molybdenum-99 in order to sustain supply.
